Genetic Testing And Risk Scores | Todd Morgan, MD & Mark Moyad, MD | #PCRI #ProstateCancer @ThePCRI
Genetic Testing And Risk Scores | Todd Morgan, MD & Mark Moyad, MD | #PCRI #ProstateCancer  @ThePCRI
Uploaded February 2026 | Updated September 2026, 2 weeks ago
Learn more about Dr. Todd Morgan here:
https://medschool.umich.edu/profile/3567/todd-morgan

To learn more about prostate cancer, visit pcri.org
Don't know your stage? Take the quiz: visit prostatecancerstaging.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join

Donate to PCRI: pcri.org/donate

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
#ElisabethHeathMD
Genetic Testing And Risk Scores | Todd Morgan, MD & Mark Moyad, MD | #PCRI #ProstateCancerCan You Stop Hormone Therapy? Alternatives to ADT for #ProstateCancer Mark Scholz, MD & Alex ScholzDiffering Opinions About #ProstateCancer Treatment | #MarkScholzMD #AlexScholz #PCRIWhat Is Gleason 6 #ProstateCancer | #MarkScholzMDFocal Therapy For #ProstateCancer | Answering Your Questions | #MarkScholzmd #AlexScholz #PCRIQuality of Life Study | 2026 Mid-Year Update | Eugene Kwon, MD + Mark Moyad, MD Q&A #PCRILearn more about Cribriform #Gleason7 #pcriLympho-Vascular Invasion (LVI) #ProstateCancer Pathology | Jonathan Epstein, MD & Mark Moyad, MDProstate MRIs in 2025 | #MarkScholzMD #AlexScholz #PCRI #ProstateCancer2025 #PCRI Mens Health Conference #MarkScholzMD #MarkMoyadMD2024 Update | Lu-177 (Pluvicto), Actinium & New #ProstateCancer AntiBody | Dr. Nat Lenzo #AlexScholz2026 #PCRI Mens Health Conference #MarkScholzMD #MarkMoyadMD
Prostate Cancer Research Institute |

Genetic Testing And Risk Scores | Todd Morgan, MD & Mark Moyad, MD | #PCRI #ProstateCancer

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER